Research with human participants

Overview of medical research in the Netherlands

Trial : NL83392.078.23

Published:
Last updated:

Publication withdrawn by sponsor

Download: PDF | XML
Ethical review
Approved WMO
Status
Other
Health condition type
Reproductive neoplasms female malignant and unspecified
Study type
Interventional

ID

NL-OMON53922

Source

ToetsingOnline

Brief title

NL83392.078.23

Condition

  • Reproductive neoplasms female malignant and unspecified

Synonym

Recurrent Ovarian Cancer / Ovarian Cancer

Research involving

Human

Sponsors and support

Primary sponsor :
Regeneron Pharmaceuticals, Inc.
Source(s) of monetary or material Support :
Industry

Intervention

Keyword :
Open-label, Ovarian Cancer

Outcome measures

Primary outcome

Publication withdrawn by sponsor

Secondary outcome

Publication withdrawn by sponsor

Background summary

Publication withdrawn by sponsor

Study objective

Publication withdrawn by sponsor

Study design

Publication withdrawn by sponsor

Intervention

Publication withdrawn by sponsor

Study burden and risks

Publication withdrawn by sponsor

Public
Regeneron Pharmaceuticals, Inc.


US
Scientific
Regeneron Pharmaceuticals, Inc.

Listed location countries

Netherlands

Age

Adults (18-64 years)
Elderly (65 years and older)

Inclusion criteria

Publication withdrawn by sponsor

Exclusion criteria

Publication withdrawn by sponsor

Design

Study phase :
2
Study type :
Interventional
Masking :
Open (masking not used)
Control :
Uncontrolled
Primary purpose :
Treatment

Recruitment

NL
Recruitment status
:
Other
Start date (anticipated) :
Enrollment :
21
Type :
Actual

Medical products/devices used

Registration
:
No

Approved WMO
Date :
Application type :
First submission
Review commission :
METC Erasmus MC, Universitair Medisch Centrum Rotterdam (Rotterdam)
Approved WMO
Date :
Application type :
First submission
Review commission :
METC Erasmus MC, Universitair Medisch Centrum Rotterdam (Rotterdam)
Approved WMO
Date :
Application type :
Amendment
Review commission :
METC Erasmus MC, Universitair Medisch Centrum Rotterdam (Rotterdam)
Approved WMO
Date :
Application type :
Amendment
Review commission :
METC Erasmus MC, Universitair Medisch Centrum Rotterdam (Rotterdam)

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
EU-CTR CTIS2024-510783-23-00
EudraCT EUCTR2019-003298-24-NL
ClinicalTrials.gov NCT03564340
CCMO NL83392.078.23